Press release content from Business Wire. The AP news staff was not involved in its creation.
Hims & Hers Appoints Two New Board Members
March 10, 2021 GMT
SAN FRANCISCO (BUSINESS WIRE) Mar 10, 2021
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today announced the appointment of Andrea Perez and Ambar Bhattacharyya to the company’s Board of Directors. Following the company’s recent entry onto the NYSE, Perez and Bhattacharyya join Hims & Hers at a pivotal moment not only for the brand, but at an inflection point in the healthcare industry as the COVID-19 pandemic has accelerated the need for equitable access to healthcare and highlighted the value of telemedicine.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
InspireMD Announces Fourth Quarter and Year-End 2020 Financial Results
InspireMD Inc.March 9, 2021 GMT
TEL AVIV, Israel, March 09, 2021 (GLOBE NEWSWIRE) InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results for the fourth quarter and year ended December 31, 2020.
Fourth Quarter 2020 and recent highlights:
Announced the closing of an upsized underwritten public offering of $20.7 million.
Announced the addition of renowned interventional cardiologist Gary Roubin, M.D., Ph.D., to the Board of Directors.